Compare SMFG & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMFG | MDT |
|---|---|---|
| Founded | 2002 | 1949 |
| Country | Japan | Ireland |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.8B | 125.3B |
| IPO Year | 1949 | N/A |
| Metric | SMFG | MDT |
|---|---|---|
| Price | $19.86 | $99.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $108.44 |
| AVG Volume (30 Days) | 1.9M | ★ 5.9M |
| Earning Date | 01-28-2026 | 02-17-2026 |
| Dividend Yield | 2.19% | ★ 2.83% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | 1.20 | ★ 3.69 |
| Revenue | $23,139,010,382.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $38.96 | $8.61 |
| Revenue Next Year | $4.37 | $5.86 |
| P/E Ratio | $27.45 | ★ $27.18 |
| Revenue Growth | N/A | ★ 5.34 |
| 52 Week Low | $11.83 | $79.55 |
| 52 Week High | $20.34 | $106.33 |
| Indicator | SMFG | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 65.68 | 58.77 |
| Support Level | $19.29 | $95.17 |
| Resistance Level | $20.34 | $96.99 |
| Average True Range (ATR) | 0.19 | 1.24 |
| MACD | -0.03 | 0.16 |
| Stochastic Oscillator | 69.35 | 80.33 |
Sumitomo Mitsui Financial Group is roughly tied with Mizuho Financial Group for the status of Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2025, its market share of domestic loans was 7.3%, compared with 8.4% for MUFG. It has a larger consumer finance business than the other two megabanks, owning 100% of the Promise business and SMBC Card. It also controls one of Japan's largest leasing companies and SMBC Aviation Capital, one of the top five aircraft lessors globally. In securities, its SMBC Nikko unit is Japan's third-largest retail broker, although SMFG has lagged somewhat in institutional securities business and asset management.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.